TLCD1 and Wilson disease: Tlcd1/2 deletion did not affect the levels of hepatic lipids or serum cholesterol in WD-fed mice, but it did reduce the overall incidence of hepatic macrovesicular steatosis (Supplementary Fig. 10f, h).